V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330004682 | 330007249 | 1.77 | 98 | Curative (C) | 2013-11-25 | 2013-12-14 | Cisplatin + Fluorouracil + RT 5day | 02 | N | 330019667 | CARBOPLATIN + RT |
| 330004683 | 330007249 | 1.67 | 58.2 | Palliative (P) | 2014-06-15 | 2014-06-26 | Cytarabine Low Dose | Y | N | 330019667 | VAI |
| 330004684 | 330007249 | 1.6 | 86.7 | Disease modification (D) | 2017-01-19 | 2017-01-23 | RUXOLITINIB | N | N | 330019667 | CISPLATIN + CYCLO + DOXORUBICIN |
| 330004685 | 330012692 | 1.72 | 72 | Curative (C) | 2016-10-25 | 2016-10-29 | BEP 3 day | 2 | N | 330019695 | CISPLATIN + FLUOROURACIL + RT |
| 330004686 | 330012692 | null | null | null | 2016-01-01 | 2016-01-02 | Docetaxel+Gemcitabine (no prior RT) | 1 | null | 330019695 | CARBOPLATIN + VINORELBINE |
| 330004688 | 330007250 | 0 | 79.1 | Not known (9) | 2014-11-16 | 2014-11-16 | Bortezomib +/- Dexamethasone | 02 | N | 330019703 | TOPOTECAN |
| 330004689 | 330007250 | 1.66 | 46.9 | Curative (C) | 2017-09-01 | 2017-09-09 | IPILIMUMAB + NIVOLUMAB | 02 | N | 330019703 | CETUXIMAB + CISPLATIN + FU |
| 330004690 | 330002261 | null | 33.6 | null | 2017-11-16 | 2017-11-17 | Vinblastine | N | null | 330019705 | BEP |
| 330004691 | 330002262 | 0 | 67.1 | Curative (C) | 2015-02-25 | 2015-03-04 | OST Euramos 1 Closed Trial - M | N | N | 330019708 | OXALIPLATIN + MDG |
| 330004692 | 330002263 | 1.7 | 72.8 | Palliative (P) | 2016-12-13 | 2016-12-27 | Cisplatin + Vinorelbine (PO) | N | N | 330019711 | CVP |
| 330004693 | 330002263 | 1.63 | 62 | Palliative (P) | 2017-02-11 | 2017-02-21 | Hydroxycarbamide | Y | N | 330019711 | DOCETAXEL + GEMCITABINE |
| 330004694 | 330002263 | 1.75 | null | Neo-adjuvant (N) | null | 2015-02-10 | CAPECITABINE + CARBOPLATIN + Cetuximab | N | N | 330019711 | CAPECITABINE + CARBOPLATIN |
| 330004695 | 330002263 | null | 16.3 | null | 2014-05-12 | 2014-05-16 | Chlorambucil | N | null | 330019711 | EDP + MITOTANE |
| 330004696 | 330002263 | 0 | 59.7 | Palliative (P) | 2017-04-25 | 2017-04-25 | Cisplatin + Fluorouracil + RT 5day | 02 | N | 330019711 | UKALL 2011 |
| 330004698 | 330002265 | 1.61 | 85 | Curative (C) | 2013-10-02 | 2013-10-02 | ECarboX | 02 | N | 330019748 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN |
| 330004699 | 330007252 | null | 57.3 | Palliative (P) | 2015-05-18 | 2015-06-07 | CARBOPLATIN + RT | N | N | 330019758 | EPIRUBICIN |
| 330004700 | 330007252 | 1.56 | 94 | Curative (C) | 2013-10-29 | 2013-10-29 | Mitotane 3 - 3.5g | Y | N | 330019758 | CISPLATIN + DOXORUBICIN + ETOPOSIDE |
| 330004701 | 330007252 | 1.86 | 70.6 | Curative (C) | 2015-08-15 | 2015-08-24 | CARBOPLATIN + RT | 02 | N | 330019758 | CYTARABINE |
| 330004702 | 330012240 | 1.67 | 49.4 | Palliative (P) | 2015-03-14 | 2015-03-27 | Cisplatin + Fluorouracil + RT 5day | 02 | N | 330019771 | CAPE + CARBOPLATIN + CETUXIMAB |
| 330004703 | 330012240 | 1.72 | null | null | 2016-06-12 | 2016-06-17 | Azacitidine | null | null | 330019771 | ETOPOSIDE + IFOSFAMIDE |
| 330004704 | 330002266 | null | 88.7 | Palliative (P) | 2016-04-14 | 2016-04-21 | Cisplatin + Vinorelbine (IV) | 02 | N | 330019776 | CAPECITABINE + OXALIPLATIN |
| 330004705 | 330002267 | 1.93 | 66.4 | Palliative (P) | 2015-12-12 | 2015-12-12 | Cytarabine Intrathecal (any age) | N | N | 330019779 | MITOTANE |
| 330004706 | 330002267 | 1.6 | 116.2 | null | null | 2017-12-27 | Docetaxel + Gemcitabine with GCSF | N | null | 330019779 | FLUOROURACIL + MITOMYCIN |
| 330004707 | 330002267 | 0 | 56.7 | Curative (C) | 2013-06-11 | 2013-06-12 | CISPLATIN + FLUOROURACIL + RT | N | N | 330019779 | CAPECITABINE + CARBOPLATIN |
| 330004708 | 330002268 | 1.78 | 104.1 | Curative (C) | 2016-02-26 | 2016-03-16 | CISPLATIN + DOXORUBICIN + METHOTREXATE | N | N | 330019789 | VINBLASTINE |
| 330004711 | 330007255 | 1.69 | 81.3 | Curative (C) | 2016-07-27 | 2016-10-10 | Vinblastine weekly | 2 | N | 330019797 | CARBOPLATIN + RT |
| 330004712 | 330002270 | 1.74 | 99.6 | Curative (C) | 2017-08-01 | 2017-08-02 | Doxorubicin + Ifosfamide | 2 | N | 330019806 | BEP |
| 330004713 | 330002271 | 1.8 | 77 | Curative (C) | 2014-08-03 | 2014-08-03 | IMATINIB | N | N | 330019807 | DOXORUBICIN + OLARATUMAB |
| 330004714 | 330002272 | 1.72 | 64.8 | Adjuvant (A) | 2013-02-20 | 2013-02-20 | TEMOZOLOMIDE | Y | N | 330019808 | CETUXIMAB + CISPLATIN + FLUOROURACIL |
| 330004716 | 330002274 | 0 | 66.4 | Curative (C) | 2016-06-15 | 2016-06-15 | Bendamustine + prednisolone | 2 | N | 330019842 | PEMBROLIZUMAB |
| 330004717 | 330007256 | 1.81 | 94 | Not known (9) | 2018-01-14 | 2018-01-14 | CNS Low Grade Glioma Vinblastine | N | N | 330019854 | BENDAMUSTINE |
| 330004718 | 330002275 | 1.72 | 89.7 | Palliative (P) | 2013-06-02 | 2013-06-05 | Doxorubicin + Olaratumab | N | N | 330019860 | DOXORUBICIN + IFOSFAMIDE |
| 330004719 | 330002276 | 1.8 | 60.5 | Palliative (P) | null | 2013-07-25 | Vinblastine | null | null | 330019869 | CARBOPLATIN + PEMETREXED |
| 330004720 | 330002277 | null | 78.7 | Palliative (P) | 2014-10-28 | 2014-10-29 | FEC 100 | Y | N | 330019886 | FLUOROURACIL + MITOMYCIN + RT |
| 330004721 | 330002277 | 1.68 | 95 | Curative (C) | null | 2013-03-24 | DOCETAXEL + GEMCITABINE | N | N | 330019886 | AZACITIDINE |
| 330004722 | 330002277 | 1.77 | 83 | Curative (C) | 2015-12-03 | 2015-12-07 | AML17 TRIAL | N | N | 330019886 | CAPECITABINE + OXALIPLATIN |
| 330004723 | 330002278 | 1.71 | 81.9 | Adjuvant (A) | 2016-03-28 | 2016-03-28 | ECX | Y | N | 330019900 | BORTEZOMIB |
| 330004724 | 330002279 | 1.99 | 60.8 | Curative (C) | 2013-10-11 | 2013-10-24 | VEPEMB | N | N | 330019906 | DOXORUBICIN + IFOSFAMIDE |
| 330004725 | 330002279 | 1.56 | 63 | Curative (C) | 2013-11-03 | 2013-11-11 | CARBOPLATIN + VINCRISTINE | 02 | N | 330019906 | CAPECITABINE + CARBOPLATIN |
| 330004726 | 330002280 | 1.95 | null | Curative (C) | 2013-10-03 | 2013-10-03 | Bortezomib (weekly) | Y | N | 330019913 | CETUXIMAB + CISPLATIN + FLUOROURACIL |
| 330004727 | 330007259 | 1.77 | 92.4 | Curative (C) | 2015-07-24 | 2015-07-24 | Cyclophosphamide Fludarabine (Oral) | N | N | 330019915 | TCF |
| 330004728 | 330007259 | 1.61 | 71.6 | Adjuvant (A) | 2017-06-30 | 2017-07-14 | ECarboX | N | N | 330019915 | FLUOROURACIL + MITOMYCIN + RT |
| 330004729 | 330002281 | 1.81 | 70.1 | Curative (C) | 2018-02-15 | 2018-02-15 | BLEOMYCIN | 02 | null | 330019918 | TCF |
| 330004730 | 330002281 | 0 | 89.7 | Adjuvant (A) | 2013-07-28 | 2013-08-20 | DOXORUBICIN + IFOSFAMIDE | N | N | 330019918 | FCR |
| 330004731 | 330002282 | 1.58 | null | null | 2014-11-03 | 2014-11-05 | Dacarbazine | N | N | 330019924 | DOCETAXEL + GEMCITABINE |
| 330004732 | 330002283 | 1.63 | 99 | Curative (C) | 2016-09-04 | 2016-09-08 | Carboplatin + Vinorelbine Oral | 02 | N | 330019928 | CISPLATIN + FLUOROURACIL + RT |
| 330004733 | 330002283 | 1.6 | 83 | Curative (C) | 2013-07-31 | 2013-08-02 | FLAG + Idarubicin | N | N | 330019928 | TEMOZOLOMIDE + RT |
| 330004734 | 330009939 | null | null | Adjuvant (A) | 2016-08-02 | 2016-08-14 | Midostaurin | N | N | 330019937 | CARBOPLATIN + RT |
| 330004737 | 330002286 | 1.64 | 77 | Palliative (P) | 2014-09-09 | 2014-09-26 | ICE-R (Cycle 2 onwards) | 02 | N | 330019960 | MIFAMURTIDE |
| 330004738 | 330002286 | 1.58 | 83.2 | Palliative (P) | 2014-09-29 | 2014-10-28 | Cyclophosphamide TBI Allograft | null | N | 330019960 | AML17 TRIAL |